Ptc Therapeutics (PTCT) Gains from Investment Securities (2012 - 2025)
Ptc Therapeutics (PTCT) posted quarterly Gains from Investment Securities of -$800000.0 for Q1 2025, down 700.0% year-over-year from $133333.3 in Q1 2024, and up 92.14% quarter-over-quarter from -$10.2 million in Q4 2024.
Powered by 
Analysis
Ptc Therapeutics (PTCT) Gains from Investment Securities (2012 - 2025) Analysis & Trends
Ptc Therapeutics' Gains from Investment Securities history runs 14 years deep, the most recent figure standing at -$800000.0 for Q1 2025.
- In Q1 2025, Gains from Investment Securities fell 700.0% year-over-year to -$800000.0; the TTM figure through Dec 2025 stood at -$800000.0 (up 82.12% YoY), while the FY2025 annual figure was -$800000.0, up 82.12% from the prior year.
- Gains from Investment Securities for Q1 2025 stood at -$800000.0, up from -$10.2 million in the prior quarter.
- The five-year high for Gains from Investment Securities was $10.8 million in Q3 2021, with the low at -$128.9 million in Q2 2023.
- The 5-year median for Gains from Investment Securities is -$100000.0 (2024), against an average of -$9.4 million.
- Peak annual rise in Gains from Investment Securities reached 152.07% in 2022, while the deepest fall reached 11800.0% in 2022.
- Ptc Therapeutics' Gains from Investment Securities stood at -$12.1 million in 2021, then jumped by 152.07% to $6.3 million in 2022, then sank by 142.86% to -$2.7 million in 2023, then sank by 276.85% to -$10.2 million in 2024, then jumped by 92.14% to -$800000.0 in 2025.
- Business Quant data shows PTCT's Gains from Investment Securities at -$800000.0 in Q1 2025, -$10.2 million in Q4 2024, and $700000.0 in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Ptc Therapeutics | 5.78 Bn | 3.55 Bn | 340.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -800,000.00 |
| Dec 31, 2024 | -10.18 Mn |
| Sep 30, 2024 | 700,000.00 |
| Jun 30, 2024 | 5.10 Mn |
| Mar 31, 2024 | -100,000.00 |
| Dec 31, 2023 | -2.70 Mn |
| Sep 30, 2023 | 1.50 Mn |
| Jun 30, 2023 | -128.90 Mn |
| Mar 31, 2023 | 2.40 Mn |
| Dec 31, 2022 | 6.30 Mn |
| Sep 30, 2022 | -5.30 Mn |
| Jun 30, 2022 | -15.20 Mn |
| Mar 31, 2022 | -11.70 Mn |
| Dec 31, 2021 | -12.10 Mn |
| Sep 30, 2021 | 10.80 Mn |
| Jun 30, 2021 | 700,000.00 |
| Mar 31, 2021 | 100,000.00 |
| Dec 31, 2020 | 6.30 Mn |
| Sep 30, 2020 | 8.40 Mn |
| Jun 30, 2020 | 7.68 Mn |